Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
M3 Inc (JP:2413)
TSE/TYO:2413
Holding JP:2413?
Track your performance easily
2413 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥1,126.50 - ¥2,527.50
Previous Close¥1,425
Volume7.44M
Average Volume (3M)5.79M
Market Cap
¥967.62B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)24.7
Beta0.96
Next Earnings
Jan 29, 2025EPS Estimate
¥18.34Last Dividend Ex-Date
Mar 28, 2024Dividend Yield1.52%
Share Statistics
EPS (TTM)57.67
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume5,790,262
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,967.08Price Target Upside38.04% Upside
Rating ConsensusHold
Number of Analyst Covering4
M3 News
PremiumCompany Announcements
M3 Inc. Reports Mixed Financial Performance for 2024
PremiumCompany Announcements
M3 Acquires Majority Stake in ELAN CorporationPremiumCompany Announcements
M3, Inc. Forges New Alliance with ELAN Corporation
PremiumCompany Announcements
M3, Inc. Aims to Acquire Majority Stake in ELAN
PremiumCompany Announcements
M3, Inc. Reports Mixed Quarterly Financials
PremiumCompany Announcements
M3, Inc. Cautions on Future Projections
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.46% Mutual Funds
― Other Institutional Investors
88.54% Public Companies and
Individual Investors
2413 FAQ
What was M3 Inc’s price range in the past 12 months?
M3 Inc lowest stock price was ¥1126.50 and its highest was ¥2527.50 in the past 12 months.
What is M3 Inc’s market cap?
Currently, no data Available
When is M3 Inc’s upcoming earnings report date?
M3 Inc’s upcoming earnings report date is Jan 29, 2025 which is in 67 days.
How were M3 Inc’s earnings last quarter?
M3 Inc released its earnings results on Oct 30, 2024. The company reported ¥8.91 earnings per share for the quarter, missing the consensus estimate of ¥13.866 by -¥4.956.
Is M3 Inc overvalued?
According to Wall Street analysts M3 Inc’s price is currently Undervalued.
Does M3 Inc pay dividends?
M3 Inc pays a Annually dividend of ¥21 which represents an annual dividend yield of 1.52%. See more information on M3 Inc dividends here
What is M3 Inc’s EPS estimate?
M3 Inc’s EPS estimate is ¥18.34.
How many shares outstanding does M3 Inc have?
M3 Inc has 679,077,200 shares outstanding.
What happened to M3 Inc’s price movement after its last earnings report?
M3 Inc reported an EPS of ¥8.91 in its last earnings report, missing expectations of ¥13.866. Following the earnings report the stock price went up 0.991%.
Which hedge fund is a major shareholder of M3 Inc?
Currently, no hedge funds are holding shares in JP:2413
---
M3 Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.64%
12-Months-Change
Fundamentals
Return on Equity
11.16%
Trailing 12-Months
Asset Growth
11.21%
Trailing 12-Months
Company Description
M3 Inc
M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.
---
2413 Stock 12 Month Forecast
Average Price Target
¥1,967.08
▲(38.04% Upside)
Technical Analysis
Best Analysts Covering 2413
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-31.05%
reiterated a buy rating 24 days ago
Copying Kyoichiro Shigemura's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -31.05% per trade.
---